Navigation Links
OPKO's Bevasiranib Named One of Most Promising Drugs Recently Entering Phase III Trials
Date:12/6/2007

MIAMI, Dec. 6 /PRNewswire-FirstCall/ -- OPKO Health, Inc. (Amex: OPK) today reported that the gene silencing agent bevasiranib, OPKO's lead compound for the treatment of wet age-related macular degeneration (wet AMD), was named one of the top five most promising drugs entering Phase III clinical trials during the third quarter of 2007. The designation was reported in the current issue of The Ones to Watch report issued by Thomson Scientific Inc. Thomson's industry experts stated that their selections this quarter are intended to "showcase the ongoing drive to find therapies for diseases that impact on ageing and sedentary populations." Data for the Thomson report was compiled and analyzed using Thomson Pharma(R), a comprehensive global pharmaceutical information solution that covers the entire drug discovery and development pipeline.

"We are very pleased to receive this recognition from Thomson Scientific since we believe bevasiranib has the potential to represent a major advance in the treatment of this common condition that limits the independence and quality of life of millions of older people around the globe," said Phillip Frost, M.D., Chairman and CEO of Opko Health. "Current vision-preserving therapy requires patients with wet AMD to receive intravitreal injections every four weeks, so the potential ability of bevasiranib to achieve similar results while requiring less frequent injections would be an important benefit for these patients, who often have limited mobility. Bevasiranib also has demonstrated excellent safety in clinical trials to date, another important consideration in this patient population."

Bevasiranib is a first-in-class small interfering RNA (siRNA) drug designed to silence the g
'/>"/>

SOURCE OPKO Health, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Keith Taft Named General Manager of UltraTape Industries
2. Summa Health Systems Akron City Hospital Named Leapfrog Top Hospital for 2007
3. Heartline(R) Fitness Systems Named to Inc. Magazines Inaugural List of the 5000 Fastest Growing Private Companies in U.S....
4. Allscripts Named to FORTUNE 100 Fastest-Growing Companies List
5. Boston Micromachines Multi-DM Named One of the Years Most Innovative Products
6. Karen Vigil Named Senior Vice President and Chief Executive Officer, Blue Shield of Californias Individual, Small Group, and Government Business Unit
7. New Director of Nursing Practice Named for Nurses Association
8. Instrumentation Laboratory Named Top of Class by Respiratory Care Managers
9. Meeting Expectations Named to First Annual CMI 25 List by Corporate Meetings & Incentives Magazine
10. Frances Decker Named Mid-Atlantic Region Sales Executive for AllOne Health Management Solutions
11. AIUM CEO named among most influential in radiology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... (PRWEB) June 03, 2015 Visual ... Analytics solutions, today announced the launch of the ... (DSX) for SAP® BusinessObjects™ Design Studio. The Design ... visualization capabilities and advanced functionalities into their dashboarding ... DSX suite, Visual BI is adding key components ...
(Date:6/3/2015)... PA (PRWEB) June 03, 2015 Sitting ... can cause discomfort in the back, neck, shoulders and/or ... other musculoskeletal injuries. In addition, recent research links sitting ... number of chronic diseases. Fortunately, three inventors from Oakville, ... sit at a desk. , They have developed a ...
(Date:6/3/2015)... Fourroux Prosthetics, located at 6630 McGinnis Ferry ... grand opening with a ribbon cutting ceremony on Wednesday, ... its kind in the area, Fourroux Prosthetics will provide ... through use of patented advanced prosthetics CAD/CAM technology. ... Prosthetics, states, “Our goal has always been to provide ...
(Date:6/3/2015)... (PRWEB) June 03, 2015 First ... freestanding emergency rooms in the United States, announced that ... facility in late June. , “I am pleased ... Texas with a new facility in the San Antonio ... of First Choice Emergency Room. , First Choice ...
(Date:6/3/2015)... Washington, DC (PRWEB) June 03, 2015 ... podiatrist Dr. Casey Friske ( Clarksville ... Podiatrist Scholarship from the Symposium of Advanced Wound Care ... by APMA President-Elect Dr. Dan Davis. The Conference ... Henry B. Gonzalez Convention Center in San Antonio, TX. ...
Breaking Medicine News(10 mins):Health News:Visual BI Launches Second Release for its Design Studio EXtensions (DSX) for SAP® BusinessObjects™ Design Studio 2Health News:Visual BI Launches Second Release for its Design Studio EXtensions (DSX) for SAP® BusinessObjects™ Design Studio 3Health News:Adjustable Height Tabletop Unit Invented by Three InventHelp® Clients (TOR-9278) 2Health News:Fourroux Prosthetics Atlanta to Have Grand Opening Gala & Ribbon Cutting Ceremony 2Health News:First Choice Emergency Room to Open New Facility in San Antonio, Texas 2Health News:Foot and Ankle Specialists of the Mid-Atlantic, LLC Receives Award at the Spring 2015 Symposium of Advanced Wound Care Conference 2
... -- The discovery of a gene pattern that distinguishes highly ... may help improve treatment of bone cancer in children, according ... species that develops bone cancer spontaneously with any frequency. Dogs ... human and dog forms of bone cancer are very similar, ...
... News) -- Youth sports programs need to have guidelines ... updated policy statement from the American Academy of Pediatrics. ... in outdoor sports and activities in a wide range ... situations that are potentially dangerous," Dr. Stephen G. Rice, ...
... new source for sexual problems among middle-aged and older ... men,s closest friends. A study published Monday, August ... Chicago and Cornell University has found a connection between ... men and their partners. They describe the situation as ...
... PHILADELPHIA In the latest issue of Nature ... the University of Pennsylvania clarify the role of two ... well-known protein called Notch passes off much of its ... T cells are required for many aspects of immunity, ...
... , SUNDAY, Aug. 7 (HealthDay News) -- Be ... of Michigan Health System,s Trauma Burn Center, which has treated ... kinds of injuries are avoidable and the painful consequences often ... in a news release from the trauma center. Most ...
... RIVERSIDE, Calif. ( www.ucr.edu ) -- A professor at ... has received a $100,000 grant to develop a new ... Dimitrios "Dimitri" Morikis, a professor of bioengineering, and ... Study of Macular Degeneration at the University of California, ...
Cached Medicine News:Health News:Study of Bone Cancer in Dogs May Improve Treatment in Kids 2Health News:Kids Can Safely Play Sports in Hot Weather: Experts 2Health News:When a man's partner is too close to his friends, his sex life may suffer 2Health News:When a man's partner is too close to his friends, his sex life may suffer 3Health News:Penn researchers describe key molecule that keeps immune cell development on track 2Health News:Professor fights disease that destroys vision 2
(Date:6/3/2015)... Research and Markets  ( http://www.researchandmarkets.com/research/rf4hfn/global ) ... Neurodegenerative Diseases Market 2015-2019" report to their ... to grow at a CAGR of 4.77% over ... the present scenario and the growth prospects of ... 2015-2019. To calculate the market size, the report ...
(Date:6/3/2015)... June 3, 2015  EIP Pharma LLC ( www.eippharma.com ... clinical development of VX-745 in Alzheimer,s disease (AD) is ... and potent inhibitor of the alpha isoform of the ... alpha). "Recent human genetic data demonstrate that ... with symptomatic Alzheimer,s, while the science also indicates the ...
(Date:6/3/2015)... , June 02, 2015 Research and ... the "Europe Ultrasound Devices Market - Growth, Trends ... offering. Currently, the European market is dominated ... of France and ... increasing incidences of chronic diseases in these regions. ...
Breaking Medicine Technology:Global Neurodegenerative Diseases Market 2015-2019 - Reformulation of Marketed Drugs 2EIP Pharma announces first patient dosing in phase 2 clinical studies of a novel brain-targeted anti-inflammatory drug candidate, VX-745, for the treatment of Alzheimer's disease (AD) 2EIP Pharma announces first patient dosing in phase 2 clinical studies of a novel brain-targeted anti-inflammatory drug candidate, VX-745, for the treatment of Alzheimer's disease (AD) 3European Ultrasound Devices Market Report 2015-2019 2
... May 4, 2012  PRO-DEX, INC. (NasdaqCM: PDEX) today announced ... months ended March 31, 2012. (Logo: ... reported a loss from continuing operations of $513,000, or ... 31, 2012 compared to income from continuing operations of ...
... (NASDAQ: AMGN ) will present at the Baird ... Four Seasons Hotel, Chicago, Ill., beginning at 8:20 a.m. Central ... Amgen, will present. Live audio of the presentation can be ... , under Investors. About Amgen ...
Cached Medicine Technology:Pro-Dex, Inc. Announces Fiscal Third Quarter and Nine Month Results 2Pro-Dex, Inc. Announces Fiscal Third Quarter and Nine Month Results 3Pro-Dex, Inc. Announces Fiscal Third Quarter and Nine Month Results 4Pro-Dex, Inc. Announces Fiscal Third Quarter and Nine Month Results 5Pro-Dex, Inc. Announces Fiscal Third Quarter and Nine Month Results 6Pro-Dex, Inc. Announces Fiscal Third Quarter and Nine Month Results 7Pro-Dex, Inc. Announces Fiscal Third Quarter and Nine Month Results 8
Designated most popular model or size. 3 mm tip....
Designated most popular model or size. Double-ended. 2 mm wide....
Designated most popular model or size. Slightly angled, 2 mm wide....
4 mm x 6 mm dissector end with shaft marked at 10 mm, 20 mm, 30 mm from tip. 6 mm wide curved elevator. Round knurled handle....
Medicine Products: